Park Ha Biological Technology Co., Ltd.
BYAH
Analytical Summary
On an absolute basis, Park Ha Biological Technology Co., Ltd. shows weak fundamentals, weighed down by Return on Invested Capital and FCF Margin (%). These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.
info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.
Bullish Indicators
- No bullish signals detected.
Bearish Risks
- Return on Invested CapitalReturn on Invested Capital of -611.5% is weak on an absolute basis (target > 10%)
- FCF Margin (%)FCF Margin (%) of 3.4% is weak on an absolute basis (target > 10%)
- FCF / Net IncomeFCF / Net Income of -0.00x is weak on an absolute basis (target > 1x)
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Secondary lens
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Unavailable
Benchmark Lens
Benchmarks are disabled until comparison data is defensible.
Benchmarks unavailable
Verdicts use absolute quality thresholds, not peer comparison — only 0 comparable companies are currently available for ranking.
Use Statement Evidence firstCompare BYAH with peers
Stack BYAH against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 5 years · 5 quarters